The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Management of Patients with Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial

Overview of attention for article published in The Journal of Urology, February 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 5 news outlets
policy: 1 policy source

twitter: 1 X user
guideline: 3 clinical guideline sources

Readers on

mendeley: 84 Mendeley

So far, Altmetric has seen 5 news stories from 5 outlets.

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

MedPage Today, 18 Apr 2022

Case Studies > Oncology/Hematology Consistently low PSA levels failed to signal metastasis by Kate Kneisel, Contributing Writer…

Around the Practice: The Management of Biochemical Recurrence in Prostate Cancer

Cancer Network, 06 May 2021

This article reviews new imaging technologies that may improve early detection of biochemical recurrence after definitive…

The Journal of Urology Publishes Results from Blue Earth Diagnostics' LOCATE Trial of Role of 18F Fluciclovine PET/CT Imaging in the Management of Men with Recurrent Prostate Cancer - Press Release

Digital Journal, 11 Sep 2018

BURLINGTON, Mass.

News story from Finanz Nachrichten on Tuesday 11 September 2018

Finanz Nachrichten, 11 Sep 2018

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 1 additional news stories.